Stockholders' Equity - Narrative (Details)				12 Months Ended
	Jul. 10, 2023 USD ($) $ / shares shares	May 30, 2022 $ / shares shares	Apr. 06, 2022 USD ($) $ / shares	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Nov. 13, 2024 USD ($)	Jan. 02, 2024 USD ($) $ / shares shares	Dec. 31, 2022 shares	Apr. 08, 2022 USD ($)
Class of Stock [Line Items]
Stock issuance costs | $				$ 0	$ 5,000
Preferred stock, shares authorized (in shares)				2,000,000	2,000,000
Preferred stock par value (in dollars per share) | $ / shares				$ 0.0001	$ 0.0001
Preferred stock, shares outstanding (in shares)				15,000	15,000
Preferred stock, shares issued (in shares)				15,000	15,000
Common stock, shares authorized (in shares)				170,000,000	170,000,000
Common stock par value (in dollars per share) | $ / shares				$ 0.0001	$ 0.0001
Common stock, shares issued (in shares)				34,056,920	29,130,607
Common stock, shares outstanding (in shares)				34,056,920	29,130,607
Loan and Security Agreement, Term loan | Term loan
Class of Stock [Line Items]
Number of shares of common stock for which warrant is exercisable (in shares)							191,096
Exercise price of warrant (in dollars per share) | $ / shares							$ 1.83
Warrants and rights outstanding | $							$ 200,000
Registered Direct Offering Pre-Funded Warrant
Class of Stock [Line Items]
Number of shares of common stock for which warrant is exercisable (in shares)		7,788,480
Discount, pre-funded warrant (in dollars per share) | $ / shares		$ 0.0001
Exercise price of warrant (in dollars per share) | $ / shares		0.0001
PIPE Purchase Agreement Pre-Funded Warrant
Class of Stock [Line Items]
Exercise price of warrant (in dollars per share) | $ / shares					$ 0.0001
Warrants exercised (in shares)					6,300,000
Gross proceeds | $					$ 630
Pre-funded warrants outstanding (in shares)					0
Armistice Warrant Agreement
Class of Stock [Line Items]
Number of shares of common stock for which warrant is exercisable (in shares)	9,900,990
Exercise price of warrant (in dollars per share) | $ / shares	$ 1.39
Gross proceeds | $	$ 13,800,000
Armistice Reload Warrant Agreement
Class of Stock [Line Items]
Number of shares of common stock for which warrant is exercisable (in shares)	3,750,000
Exercise price of warrant (in dollars per share) | $ / shares	$ 5.13
Warrants and rights outstanding, term	54 months
Ownership limitation	0.0999
Common stock
Class of Stock [Line Items]
Common stock, shares outstanding (in shares)				34,056,920	29,130,607			12,163,673
At-The-Market Offering | Common stock
Class of Stock [Line Items]
Issuance of stock (in shares)				4,718,923	640,944
Registered Direct Offering
Class of Stock [Line Items]
Stock price (in dollars per share) | $ / shares		$ 1.39
Preferred shares sold (in shares)		844,613
Series X Convertible Preferred Stock
Class of Stock [Line Items]
Interest rate			1.00%
Common stock trading price (in dollars per share) | $ / shares			$ 22.00
Common stock trading period			30 days
Accreted amount | $				$ 300,000
Conversion price (in dollars per share) | $ / shares			$ 11.00
Convertible preferred stock (in shares)			91
Outstanding common stock			9.90%
Outstanding common stock, not to exceed			19.90%
Percentage of investment owned			50.00%
Maximum working capital line | $			$ 5,000,000
Sale of stock consideration | $			15,000,000
Stock issuance costs | $			100,000
Net proceeds | $			14,900,000
DaVita | Series X Convertible Preferred Stock | Private Placement
Class of Stock [Line Items]
Consideration authorized | $			$ 15,000,000
Stock price (in dollars per share) | $ / shares			$ 1,000
Cantor Fitzgerald & Co | At-The-Market Offering
Class of Stock [Line Items]
Consideration authorized | $						$ 25,000,000.0			$ 12,200,000
Sale of stock consideration | $				10,200,000
Remaining consideration on ATM facility | $				$ 21,100,000